Colgate-Palmolive Company's ($CL) stock has experienced notable transformations reflected by various asset management and investment entities. Its buoyant phase has led
DnB Asset Management and
Banque Transatlantique SA to buy a significant number of shares. It also reached an impressive
$491.58 million stock position held by
Amundi. Growth optimism is surrounding
CL though it's apparently lacking in certain areas. However,
AlphaQuest LLC still maintains a
$483,000. position in CL and
Advisors Asset Management Inc. has bought 10,105 shares. CL's Q2 2025 earnings exceeded expectations despite pressure on margins. This positive report indicates a potential long-term dividend income, which reassures investors of their investment's stability. Strong momentum is recognized in Colgate-Palmolive (CL) stock and it's considered a recommended FMCG stock to buy according to hedge funds. However, stock transactions also reflect a degree of uncertainty with a number of entities like
AQR Capital Management LLC and
Vident Advisory LLC selling their shares. CL also had a drop of 1.43% due to CEO Noel Wallace's presentation at Barclays 18th, but it remains resilient amidst challenges. A significant development includes Colgate-Palmolive settling a
$332-million dispute with employees over pensions.
Colgate-Palmolive Company CL News Analytics from Sat, 08 Feb 2025 08:00:00 GMT to Sat, 06 Sep 2025 13:38:40 GMT -
Rating 3
- Innovation -4
- Information 5
- Rumor 2
